@Mcdivot06 @SeekingAlpha Advantageous for $AMGN if $ARWR remained a diminutive bio, but BP knows where RNAi is headed. AMG-890 is a byproduct of this comprehension. $JNJ understands collaborations are progressive &amp; help offset the impending revenue stream invasion by biosimilars.https://t.co/7i2OsYwMKJ